12:00 AM
 | 
Jun 18, 2012
 |  BC Week In Review  |  Company News  |  Deals

EUSA, Jazz Pharmaceuticals deal

Jazz completed its acquisition of EUSA for $680 million in cash, plus a potential $50 million milestone payment tied to 2013 U.S. sales of EUSA's Erwinaze. The transaction was financed...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >